Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal francais d'ophtalmologie 2020-06, Vol.43 (6), p.548
1. Verfasser:	Defoort-Dhellemmes, S
Format:	Artikel
Sprache:	fre
Schlagworte:	Antimalarials - administration & dosage Antimalarials - adverse effects Betacoronavirus Bone Density Conservation Agents - adverse effects Contraindications, Drug Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology COVID-19 Humans Hydroxychloroquine - administration & dosage Hydroxychloroquine - adverse effects Obesity - complications Pandemics Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Renal Insufficiency - complications Retinal Diseases - chemically induced Risk Factors SARS-CoV-2 Tamoxifen - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!